OTC Markets OTCQX - Delayed Quote USD

Enzon Pharmaceuticals, Inc. (ENZN)

0.0900
0.0000
(0.00%)
At close: May 9 at 4:00:00 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
26
26
0
26
701
Operating Expense
1,353
1,353
1,044
1,058
1,170
Operating Income
-1,327
-1,327
-1,044
-1,032
-469
Net Non Operating Interest Income Expense
2,452
2,452
2,261
646
--
Other Income Expense
--
--
--
646
7
Pretax Income
1,125
1,125
1,217
-386
-462
Tax Provision
347
347
-156
-200
7
Net Income Common Stockholders
-497
-497
98
-1,461
-2,492
Diluted NI Available to Com Stockholders
-497
-497
98
-1,461
-2,492
Basic EPS
-0.01
-0.01
0.00
-0.02
-0.03
Diluted EPS
-0.01
-0.01
0.00
-0.02
-0.03
Basic Average Shares
74,215
74,215
74,215
74,215
74,215
Diluted Average Shares
74,215
74,215
74,215
74,215
74,215
Total Operating Income as Reported
-1,327
-1,327
-1,044
-1,032
-469
Total Expenses
1,353
1,353
1,044
1,058
1,170
Net Income from Continuing & Discontinued Operation
778
778
1,373
-186
-469
Normalized Income
778
778
1,373
-186
-469
Interest Income
2,452
2,452
2,261
646
--
Net Interest Income
2,452
2,452
2,261
646
--
EBIT
-1,327
-1,327
-1,044
-1,032
-469
EBITDA
-1,327
-1,327
-1,044
-1,032
-469
Net Income from Continuing Operation Net Minority Interest
778
778
1,373
-186
-469
Normalized EBITDA
-1,327
-1,327
-1,044
-1,032
-469
Tax Rate for Calcs
0.0003
0.0003
0.0002
0.0002
0.0003
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/15/1984

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

IMUC EOM Pharmaceuticals Holdings, Inc.
0.1050
0.00%
 
PHVS Pharvaris N.V.
16.99
-0.29%
 
EXOZ eXoZymes, Inc.
13.01
+2.68%
 
GTBP GT Biopharma, Inc.
2.2700
-2.58%
 
NERV Minerva Neurosciences, Inc.
1.6100
-0.62%
 
UPB Upstream Bio, Inc.
8.82
-0.23%
 
SNSE Sensei Biotherapeutics, Inc.
0.3600
-4.41%
 
CLGN CollPlant Biotechnologies Ltd.
1.8200
-0.55%
 
AURA Aura Biosciences, Inc.
5.23
-9.83%
 
VRAX Virax Biolabs Group Limited
1.0500
-0.94%